Literature DB >> 8093703

Differentiation driven by granulocyte-macrophage colony-stimulating factor endows microglia with interferon-gamma-independent antigen presentation function.

H G Fischer1, B Nitzgen, T Germann, K Degitz, W Däubener, U Hadding.   

Abstract

The antigen presentation function of microglial cells was analyzed after differentiation in neonatal mouse brain cell cultures supplemented either with macrophage (M) or granulocyte/macrophage (GM) colony-stimulating factor (CSF). The cells separated from concomitant astrocytes in both culture systems turned out to exhibit cytological characteristics of macrophages and bore MAC-1 and F4/80 markers in a similar way. When comparatively tested for accessory cell function, only microglia developed with GM-CSF were able to efficiently induce antigen-directed proliferation of a series of helper T cell lines representing both the TH1 and TH2 subtype. Antigenic T cell activation by this microglia population was performed without prior stimulation and exceeded that of M-CSF-dependently grown microglial cells, even if those had been pretreated with interferon-gamma (IFN-gamma). In contrast to such difference in function, low cell surface expression of MHC class II or intercellular adhesion molecule-1 determinants proved to coincide in both populations. Correlating with the capacity for antigen presentation, expression of membrane-bound interleukin-1 (IL1)--a costimulatory signal for TH2 cells--was augmented significantly in GM-CSF-grown microglia. In parallel, the interaction only of this microglia population with a selected TH1 cell line was accompanied by maximal release of T cell-stimulating factor, a cytokine recently identified as an IL1-analogous second signal for TH1 cells. Thus, a developmental process is suggested which produces a form of microglia specialized in antigen presentation and thereby acting uncoupled from IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093703     DOI: 10.1016/0165-5728(93)90215-k

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

1.  Astrocytes inhibit microglial surface expression of dendritic cell-related co-stimulatory molecules through a contact-mediated process.

Authors:  Giselles Acevedo; Nischal K Padala; Li Ni; G M Jonakait
Journal:  J Neurochem       Date:  2013-03-27       Impact factor: 5.372

2.  Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease mice.

Authors:  Tomomi Kiyota; Jatin Machhi; Yaman Lu; Bhagyalaxmi Dyavarshetty; Maryam Nemati; Izumi Yokoyama; R L Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2018-03-17       Impact factor: 3.478

3.  Detection of a novel 40,000 MW excretory Toxoplasma gondii antigen by murine Th1 clone which induces toxoplasmacidal activity when exposed to infected macrophages.

Authors:  G Reichmann; S Stachelhaus; R Meisel; M N Mévélec; J F Dubremetz; H Dlugonska; H G Fischer
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

4.  Granulocyte-macrophage colony-stimulating factor modulates rapid eye movement (REM) sleep and non-REM sleep in rats.

Authors:  M Kimura; T Kodama; M C Aguila; S Q Zhang; S Inoue
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

Review 5.  Colony stimulating factors in the nervous system.

Authors:  Violeta Chitu; Fabrizio Biundo; E Richard Stanley
Journal:  Semin Immunol       Date:  2021-11-04       Impact factor: 11.130

6.  Properties of voltage-gated potassium currents of microglia differentiated with granulocyte/macrophage colony-stimulating factor.

Authors:  C Eder; H G Fischer; U Hadding; U Heinemann
Journal:  J Membr Biol       Date:  1995-09       Impact factor: 1.843

Review 7.  The role of trophic factors and autocrine/paracrine growth factors in brain metastasis.

Authors:  D G Menter; J L Herrmann; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1995-03       Impact factor: 5.150

8.  Is Pre-Symptomatic Immunosuppression Protective in CSF1R-Related Leukoencephalopathy?

Authors:  Philip W Tipton; E Richard Stanley; Violeta Chitu; Zbigniew K Wszolek
Journal:  Mov Disord       Date:  2021-02-15       Impact factor: 10.338

9.  Effects of low dose GM-CSF on microglial inflammatory profiles to diverse pathogen-associated molecular patterns (PAMPs).

Authors:  Nilufer Esen; Tammy Kielian
Journal:  J Neuroinflammation       Date:  2007-03-20       Impact factor: 8.322

Review 10.  Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity.

Authors:  Vanesa Sanchez-Guajardo; Christopher J Barnum; Malú G Tansey; Marina Romero-Ramos
Journal:  ASN Neuro       Date:  2013-04-30       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.